文献速递胸部肿瘤放疗放疗物理与技术

多目标多技术优化用于放疗计划设计

Multiobjective, Multidelivery Optimization for Radiation Therapy Treatment Planning.
PubMed 文献 · Adv Radiat Oncol · 2019-09-27

研究提出多目标、多技术优化(MODO)方法,针对30例局部晚期肺癌患者,基于4个危及器官和4种照射技术生成替代计划,评估其符合准约束(QC)条件的情况并揭示剂量学权衡。结果显示多数患者存在危及器官平均剂量变化超过5 Gy的替代计划,最常见的显著权衡是提高PTV最大剂量以降低危及器官剂量。

要点

  • MODO可为每例患者生成M(N+1)个替代计划,覆盖多种照射技术和危及器官权衡。
  • 30例肺癌中,24例同侧肺、29例对侧肺和食管、19例心脏的平均剂量变化超过5 Gy。
  • 4野计划较9野计划平均降低全肺V20 10.4%±8.3%,但PTV最大剂量增加5.3±5.9 Gy。

核心结论

  • MODO生成的计划具有临床相关性,符合QC条件并展示危及器官剂量变化。

研究设计与样本

  • 方法学研究,针对30例局部晚期肺癌病例,基于4个危及器官(双肺、心脏、食管)和4种照射技术生成替代计划。

主要发现

  • 600个计划中,平均PTV-D95=67.6±2.1 Gy,PTV-Dmax=79.8±5.2 Gy,脊髓Dmax为51.4 Gy。
  • 30例中19例存在危及器官平均剂量降低超过5 Gy的统计学显著权衡,7例涉及多个危及器官至少5 Gy的权衡。
  • 最常见的显著权衡是提高PTV-Dmax以降低危及器官剂量,见于30例中的15例。
  • 4野计划较9野计划平均降低全肺V20 10.4%±8.3%,PTV-Dmax增加5.3±5.9 Gy;较27野非共面计划降低7.7%±7.9%,PTV-Dmax增加4.6±5.6 Gy;较2弧非共面计划降低11.7%±10.3%,PTV-Dmax增加9.3±7.3 Gy。

关键数值与推荐

  • 统计学显著剂量学权衡定义为决定系数>0.8且剂量学指标变化至少5 Gy。
  • QC条件包括PTV的D95、PTV最大剂量和脊髓最大剂量。

临床怎么用

  • 临床可借助MODO生成多技术替代计划,在满足QC条件的前提下可视化危及器官剂量权衡,辅助个体化选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To introduce multiobjective, multidelivery optimization (MODO), which generates alternative patient-specific plans emphasizing dosimetric trade-offs and conformance to quasi-constrained (QC) conditions for multiple delivery techniques. METHODS AND MATERIALS: For M delivery techniques and N organs at risk (OARs), MODO generates M (N + 1) alternative treatment plans per patient. For 30 locally advanced lung cancer cases, the algorithm was investigated based on dosimetric trade-offs to 4 OARs: each lung, heart, and esophagus (N = 4) and 4 delivery techniques (4-field coplanar intensity modulated radiation therapy [IMRT], 9-field coplanar IMRT, 27-field noncoplanar IMRT, and noncoplanar arc IMRT) and conformance to QC conditions, including dose to 95% (D95) of the planning target volume (PTV), maximum dose (Dmax) to PTV (PTV-Dmax), and spinal cord Dmax. The MODO plan set was evaluated for conformance to QC conditions while simultaneously revealing dosimetric trade-offs. Statistically significant dosimetric trade-offs were defined such that the coefficient of determination was >0.8 with dosimetric indices that varied by at least 5 Gy. RESULTS: Plans varied mean dose by >5 Gy to ipsilateral lung for 24 of 30 patients, contralateral lung for 29 of 30 patients, esophagus for 29 of 30 patients, and heart for 19 of 30 patients. In the 600 plans, average PTV-D95 = 67.6 ± 2.1 Gy, PTV-Dmax = 79.8 ± 5.2 Gy, and spinal cord Dmax among all plans was 51.4 Gy. Statistically significant dosimetric trade-offs reducing OAR mean dose by >5 Gy were evident in 19 of 30 patients, including multiple OAR trade-offs of at least 5 Gy in 7 of 30 cases. The most common statistically significant trade-off was increasing PTV-Dmax to reduce dose to OARs (15 of 30). The average 4-field plan reduced total lung V20 by 10.4% ± 8.3% compared with 9-field plans, 7.7% ± 7.9% compared with 27-field noncoplanar plans, and 11.7% ± 10.3% compared with 2-arc noncoplanar plans, with corresponding increases in PTV-Dmax of 5.3 ± 5.9 Gy, 4.6 ± 5.6 Gy, and 9.3 ± 7.3 Gy. CONCLUSIONS: The proposed optimization method produces clinically relevant treatment plans that meet QC conditions and demonstrate variations in OAR doses.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Watkins WT, Nourzadeh H, Siebers JV, et al. Multiobjective, Multidelivery Optimization for Radiation Therapy Treatment Planning. Adv Radiat Oncol. 2019. PMID: 32280828. doi:10.1016/j.adro.2019.09.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。